News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Food and Drug Administration (FDA)
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
Flexion Therapeutics Reports FDA Clinical Hold For Phase 2b Trial Of Osteoarthritis Drug
September 18, 2014
·
2 min read
FDA
Auxilium Pharmaceuticals, VIVUS, Inc.'s Faster-Acting Erectile Dysfunction Drug Wins FDA Approval
September 18, 2014
·
2 min read
Biotech Bay
FDA May Have Cracked Down, But 23andMe, Inc. Exec Remains Hopeful
September 17, 2014
·
1 min read
Drug Development
Regeneron Pharmaceuticals, Inc. Wins Breakthrough Therapy Designation From FDA For EYLEA
September 16, 2014
·
2 min read
FDA
FDA Approves Baxter International, Inc., Halozyme Therapeutics, Inc.'s HYQVIA
September 15, 2014
·
2 min read
FDA
FDA Panel Recommends Approval Of NPS Pharmaceuticals, Inc.'s Natpara To Treat Hypoparathyroidism
September 12, 2014
·
1 min read
Policy
FDA’s Surprise Visit To Sun Pharmaceutical Industries Ltd’s Pressures Stock
September 12, 2014
·
2 min read
Policy
Novo Nordisk A/S’s Liraglutide Safe, Effective For Obesity: FDA Panel
September 12, 2014
·
2 min read
FDA
FDA Approves Orexigen’s Long-Awaited Weight Loss Drug Contrave
September 11, 2014
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
June 28, 2026
·
13 min read
Press Releases
Anivive Lifesciences Announces FDA Approval of Laverdia®, the First Oral Treatment of Its Kind for Canine Lymphoma
June 28, 2026
·
4 min read
Press Releases
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
June 28, 2026
·
6 min read
Press Releases
PharmaEssentia Announces FDA Approval and U.S. Launch of BESREMi Pen™ (ropeginterferon alfa-2b-njft) for Polycythemia Vera
June 26, 2026
·
5 min read
Press Releases
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
June 26, 2026
·
4 min read
Press Releases
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
June 25, 2026
·
19 min read
Press Releases
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer
June 25, 2026
·
19 min read
Press Releases
TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
June 25, 2026
·
10 min read
Press Releases
FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
June 25, 2026
·
17 min read
Press Releases
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities
June 24, 2026
·
8 min read
